Conference Room

Workshop Room

Conference Room

Joseph Cuschieri

What key drivers were behind the introduction of the production of cannabis for medicinal use act?

Hon. Miriam Dalli

09:20-09:30

Research & Development

How has the change in law affected scientific research in Malta?

Hon. Deo Debattista

09:30-10:15

The Future of CBD in Europe

The emergence of CBD has driven a great amount of product innovation as consumers seek out the compound for its wellness benefits. Amidst the explosive growth however, European businesses must pay close attention to shifting market regulations, including the recent addition of cannabis extracts to the EU’s Novel Foods Catalogue. This panel will provide an overview of the current landscape and a look ahead to the proliferation of CBD across the full health products supply-chain.

Richard Sharp

Jon Liebling

Henri Sant-Cassia

Sana-Ara Ahmed

10:15-10:30

From Tragedy to Triumph

One Cancer Mom’s Journey to Find a Cure

Tracy Ryan

10:30-11:00

Medical Research on the Endocannabinoid System

Emotional Memory Acquisition – Patrizia Campolongo

The role of the endocannabinoid system as an emotional buffer for stressful memories.

Alternative Options – Giuseppe Di Giovanni

The argument for boosting the body’s natural endocannabinoids.

Sex Differences in Cannabinoid-Related Behaviours – Liana Fattore

Can the hormone-driven differentiation of the brain endocannabinoid system represent a biological basis for male-female differences in cannabinoid sensitivity?

Marcus Ramkissoon

Anne Katrin Schlag

What steps does a company need to take to operate a successful medical cannabis business?

Yona Levy

11:50-12:00

Transforming Cannabis into Mainstream Healthcare with Real World Evidence

Data integrity and quality must be assessed from both a regulatory and practitioner’s perspective. Let’s consider the various stakeholder positions in light of today’s stringent safety and efficacy protocols in the industry.

Prad Sekar

12:00-12:20

Synthetic Cannabinoids

what are the benefits and disadvantages of man-made cannabinoids?

Manit Patel

12:20-12:30

Regulation in Malta

What can Malta learn from different regulatory approaches?

Alexander Pombo

Start-up Pitch

Investment Opportunities

14:00-14:10

Case Study

From concept to exit, review of a successful start-up investment.

14:10-14:20

Hemp vs. Non-hemp Cannabis - Alpha Through the Vapor

Exploring the immense social, medical impact and economic impact the industry will have on the rest of the world.

Sumit Mehta

Monica Vialpando

14:30-14:40

Legal Cannabis

From disruption to mass market.

Vladas Snieckus

15:00-15:10

The US Medical Cannabis Industry

An overview of this growing market, its potential for development and the impact of legislative changes at both the state and federal level.

William J. Pascrell, III

15:10-15:30

Fund Restrictions

Depending on the type of funds they have access to, some investors cannot put capital into the cultivation of the crop, only technology and services that are not related to the plant itself. How is this restricting start-ups from getting the capital they need?

Mark Hamade

15:30-15:40

Real Estate Investment

Planning the acquisition, design and construction of a medical cannabis facility.

Daniel Sax

15:40-15:50

Pharmaceutical Cannabis Investments

The best of the best.

Steele Clark Smith III

15:50-16:00

Ancilliary Services

What sort of investment is required in ancillary services in order to support the medical cannabis sector?

16:00-16:20

From ICO's to Cannabis

Following the recent pitfall that many investors have experienced with ICO’s worldwide, could cannabis pave the way for more secure investment opportunities?

16:20-16:30

Raising Capital in the US

Raising capital while maintaining compliance with applicable state and federal regulations and FDA compliance.

Dave Rodman

16:30-16:40

The Hemp Opportunity

This presentation will be for serious investors interested in constructing a diversified cannabis portfolio with a deep focus on hemp. How does China impacts the global CBD market? How are the three distinct CBD channels growing and how are prices changing for the various parts of the hemp and CBD supply chain?

Sumit Mehta

16:50-17:10

VC's and PE

Venture capitalists and private equity funds are heavily involved in the North American medical cannabis market. How does this compare to Europe?

Matthew Nordgren

17:10-17:20

Going Public

IPO’s are happening in Canada. Will the trend move to Europe?

17:20-17:30

Investors and Society

As investment firms look for more socially responsible projects to put their money, how is the medical cannabis industry benefiting?

Amber Senter

17:30-17:40

Pick and Shovel Play

How are investors using this strategy to mitigate risk in volatile cannabis stocks?

17:50-18:00

Traditional Financing Models

How is stigma and uncertainty preventing medical cannabis companies from raising capital from banks and lending institutions and how can this be addressed?

Mark Hamade

Workshop Room

Emerging Medical Cannabis Markets

09:00-09:45

Malta

Andrew Agius

09:45-10:30

United Kingdom

Dani Gordon

10:30-11:15

Thailand

11:15-12:00

Switzerland

Neville Edel

12:00-12:45

Australia

Established Medical Cannabis Markets

13:45-14:30

Netherlands

14:30-15:15

Canada

Preet Marwaha

15:15-16:00

LatAM

Alexander Pombo

16:00-16:45

United States

William J. Pascrell, III

Steele Clark Smith III

16:45-17:30

Israel

5thNovember

Conference Room

Social Impact & Education

09:00-09:10

Public Sector Healthcare

Medical Cannabis in the Maltese Public Sector

Hon. Chris Fearne

09:10-09:30

Patient-led Change

How did Hannah Deacon push for legislative change in the UK and what has been the outcome of her efforts?

Hannah Deacon

Michael Barnes

09:30-09:50

Educating the Public on Medical Cannabis

What sort of public awareness campaigns are needed to destigmatize cannabis and give appropriate information on the options available.

Will Stewart

Basia Zieniewicz

Robin Emerson

William Levine

09:50-10:10

Social Impact in North America

What can North American sociological research on the affects of medical cannabis teach European countries?

Maya Elisabeth

Alix Hadley

Anthony Bailey

10:10-10:20

Mental Health

Managing and treating mental health disorders with medical cannabis

Shira Adler

Jon Liebling

10:20-10:40

Educating Medical Professionals

What are the most effective ways of educating the medical community on cannabis?

Michael Miller

Dani Gordon

Julie Moltke

10:40-11:00

Homegrown Medical Cannabis

The argument for and against regulation of private medical cannabis cultivation for patients taking it for long-term pain management.

Carly Barton

11:10-11:30

Marketing and The Last Mile

How consumers get products, touching on regulatory matters in marketing and payments especially around CBD.

Richard Skaife

11:30-11:50

Battle of the Jurisdictions

In this animated discussion, legal experts from various jurisdictions will go head to head in explaining which state is leading the way with regulatory innovation.

Joe Rogoway

Daniel Torres Gonçalves

11:50-12:00

Europe-Wide Legislation

What initiatives are in place for the harmonization of licencing medical cannabis across Europe?’

Gabriel Micallef

12:00-12:20

Sports Injuries

Using medical cannabis to aid sports recovery and pain relief in athletes.

Jean-Martin Gauthier

12:20-12:30

CBD Regulation

Challenges to regulating CBD globally.

Marija Obradovic

12:30-12:40

Medical Cannabis Policies to Support Women's Health

The importance of advocating for better medical cannabis policies to support women’s health for example, issues such as recovering from sexual assault/trauma, reproductive health conditions such as endometriosis and sexual health.

Halima Al-Hatimy

13:00-13:10

Medical Cannabis in Malta

Past, Present and Future.

Andrew Agius

13:10-13:20

Brand Management

Developing a medical cannabis brand people will care about.

Rachel Colic

Technology & Security

14:00-14:20

The Advantages of Blockchain Technology

How will blockchain disrupt this sector and help it to become more lucrative and competitive.

Aviya Arika

Ian Mcafee

Alex Cahana

Felix Mago

14:20-14:30

How to Empower the Black Market

This is the worst possible time to pretend to ignore the epidemic of counterfeiting and unregulated medical cannabis products. Bad actors pose a destructive threat to the fast-emerging industry and its patients. What to do? Join former CIA profiler and solo sciences founder and CEO Ashesh (Alex) Shah, to learn about the cryptographically-secure solo* cannabis product authentication system.

Alex Shah

14:30-14:40

From Cultivation to Waste Disposal

How is Malta preparing to address the environmental requirements?

Oliver Fenech

14:40-15:10

Technology in the US

Technological innovations in the US cannabis industry.

Jacquie Cohen Roth

Michael Patterson

15:10-15:30

Digitising Medical Prescriptions

How to secure medical records to prevent fraud and maintain patient privacy.

Neil Stansbury

15:20-15:30

Solar Energy

How Malta’s medical cannabis industry can benefit from going solar.

15:30-15:40

Large Scale Cultivation & Extraction

What are the best practices for the design, build and marketing of cultivation and extraction facilities in Israel, US and Canada?

Adam Shuster

15:40-15:50

Greenhouse Climate Management

Managing the climate of a greenhouse, specifically the humidity and how it interplays with temperature, energy consumption, plant growth, disease prevention, and uniformity.

Yanor Yazma

15:50-16:00

Going Global

The case for Building a Quality Culture and GMP Compliance.

Laleh Bighash

16:00-16:10

Security Concerns

What can Malta learn about security from international growers

Yosi Sherman

16:20-16:30

The Next Generation

How to develop the next generation of medical cannabis products with better, scientifically backed technology.

William Levine

16:20-16:30

Quality Control

How are ISO and EU standards for vaping technology driving the industry’s quality control measures forward?

Arnaud Dumas de Rauly

16:30-16:40

How Crypto is Solving the Cash Problem in the Medical Cannabis Industry

Felix Mago

The complexity of growing cannabis as a source of active pharmaceutical ingredients for the medicinal drug industry.

Sharan Sidhu

16:50-17:10

Extraction Equipment

The complex process of extraction requires cutting edge technology and highly-trained professionals. What are the financial and recruitment implications of setting up an extraction facility?

17:20-17:40

Importance of Transpositions Stability for Consistency and Best Expression of Cannabinoids

Transposons are jumping genes, which are sensitive to the environmental changes. Different genes are arranged to express secondary metabolites to sustain in the micro-macro environmental stress. Hence it is important to understand the genetics for medicinal use of cannabis.

Srinivasa Reddy

17:40-17:50

Automation

Smart systems are making headway in agricultural and horticultural spheres. How are they changing the game for medical cannabis growers?

17:50-18:00

Nano-Cannabinoid Technology

What are the pros and cons of this new technology?

Workshop Room

Seed-to-patient Tracking with Blockchain Technology

09:00-09:30

How is blockchain technology revolutionising the medical cannabis supply chain?

Petar Savic

Ian Mcafee

09:30-10:00

Approaching medical cannabis policies in the context of emerging technologies